Q4: 2026-02-02 Earnings Summary

EPS of $0.10 beats by $0.04

| Revenue of $704.78M (3.48% Y/Y) beats by $18.34M

Healthpeak Properties, Inc. (DOC) Q4 2025 Earnings Call February 3, 2026 10:00 AM EST

Company Participants

Andrew Johns - Senior Vice President of Investor Relations Scott Brinker - President, CEO & Director Kelvin Moses - Chief Financial Officer Scott Bohn - Chief Development Officer & Head of Lab

Conference Call Participants

Nicholas Yulico - Scotiabank Global Banking and Markets, Research Division Farrell Granath - BofA Securities, Research Division Austin Wurschmidt - KeyBanc Capital Markets Inc., Research Division Richard Anderson - Cantor Fitzgerald & Co., Research Division Nicholas Joseph - Citigroup Inc., Research Division Juan Sanabria - BMO Capital Markets Equity Research Wesley Golladay - Robert W. Baird & Co. Incorporated, Research Division Vikram Malhotra - Mizuho Securities USA LLC, Research Division Michael Mueller - JPMorgan Chase & Co, Research Division Omotayo Okusanya - Deutsche Bank AG, Research Division James Kammert - Evercore ISI Institutional Equities, Research Division John Pawlowski - Green Street Advisors, LLC, Research Division James Feldman - Wells Fargo Securities, LLC, Research Division

Presentation

Operator

Good morning, and welcome to the Healthpeak Properties, Inc. Fourth Quarter 2025 Conference Call. [Operator Instructions]

Please note this event is being recorded. I would now like to turn the conference over to Andrew Johns, Senior Vice President, Investor Relations. You may begin.

Andrew Johns Senior Vice President of Investor Relations

Welcome. Today’s conference call contains certain forward-looking statements. Although we believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, these statements are subject to risks and uncertainties that may cause actual results to differ materially from expectations.

A discussion of risks and risk factors is included in our press release and detailed in our filings with the SEC. We do not undertake a duty to update any forward-looking statements. Certain non-GAAP financial measures will be discussed on this call. In exhibit to the 8-K we furnished to the SEC yesterday, we have reconciled all non-GAAP